Summaries for patients. The cost-effectiveness of screening for Chlamydia in women 15 to 29 years of age.
D000293:Adolescent; D000328:Adult; D002690:Chlamydia Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control; D002692:Chlamydia trachomatis; D003198:Computer Simulation; D003362:Cost-Benefit Analysis; D005260:Female; D017048:Health Care Costs; D006801:Humans; D008403:Mass Screening / Q000191:economics*; D019057:Quality-Adjusted Life Years; D012680:Sensitivity and Specificity